Hopp til innhold
NHI.no
Annonse

Gallegangskreft: Symptomer

Innhold i artikkelen

Symptomene avhenger av hvor i galletreet svulsten befinner seg. Når svulsten sitter i en litt større gren av gallegangene, kan drenasjen av galle blokkeres. Dette fører til de typiske symptomene med smertefri gulsott, avbleket avføring, mørk urin og kløe. Befinner svulsten seg inne i leveren, vil den oftest gi ukarakteristiske symptomer som slapphet, vekttap og magesmerter.

Annonse

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Kolangiokarsinom . Referanselisten for dette dokumentet vises nedenfor

  1. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD. Cholangiocarcinoma. Lancet 2005; 366: 1303-14. PubMed
  2. Kreftregisteret. Cancer in Norway 2017. Oslo: Kreftregisteret, 2018, www.kreftregisteret.no.
  3. Line P-D. Kreft i galleganger/-blære. Oncolex. Sist rev. 20.10.2014
  4. Espat NJ, Somasundar P. Cholangiocarcinoma. BMJ Best Practice, last updated Oct 2018.
  5. Brown KM, Parmar AD, Geller DA. Intrahepatic cholangiocarcinoma. Surg Oncol Clin N Am 2014; 23:231. PubMed
  6. McGee EE, Castro FA, Engels EA, Freedman ND, Pfeiffer RM, Nogueira L, et al. Associations between autoimmune conditions and hepatobiliary cancer risk among elderly US adults. Int J Cancer. 2018 Aug 28. PMID: 30155920. PubMed
  7. Shaib YH, El-Serag HB, Davila JA, Morgan R and McGlynn KA. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 2005; 128: 620-6. Gastroenterology
  8. Donato F, Gelatti U, Tagger A et al. Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy. Cancer Causes Control 2001; 12: 959-64. PubMed
  9. Blechacz B, Komuta M, Roskams T, Gores GJ. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 2011; 8:512. PubMed
  10. Khan SA, Davidson BR, Goldin RD, et al; British Society of Gastroenterology. Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut. 2012;61:1657-1669. PubMed
  11. van Leeuwen DJ and Reeders JW. Primary sclerosing cholangitis and cholangiocarcinoma as a diagnostic and therapeutic dilemma. Ann Oncol 1999; 10 (Suppl 4): 89-93.
  12. Lassen K, Mortensen K. Retningslinjer NGICG-HPB. Kolangiocarcinomer. Norsk Gastrointestinal Cancer Gruppe. Feb 2019. ngicg.no
  13. Iavarone M, Piscaglia F, Vavassori S, et al. Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis. J Hepatol 2013; 58:1188. PubMed
  14. Anderson CD, Rice MH, Pinson CW, Chapman WC, Chari RS and Delbeke D. Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 2004; 8: 90-7. PubMed
  15. Kato T, Tsukamoto E, Kuge Y et al. Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer. Eur J Nucl Med Mol Imaging 2002; 29: 1047-54. PubMed
  16. Anderson CD, Pinson CW, Berlin J and Chari RS. Diagnosis and treatment of cholangiocarcinoma. Oncologist 2004; 9: 43-57. PubMed
  17. Jarnagin WR and Shoup M. Surgical management of cholangiocarcinoma. Semin Liver Dis 2004; 24: 189-99. PubMed
  18. Berr F. Photodynamic therapy for cholangiocarcinoma. Semin Liver Dis 2004; 24: 177-87. PubMed
Annonse
Annonse